Inventor · disambiguated record
Shoichi Hazama
Also filed as: HAZAMA SHOICHI
11 granted patents·3 pending applications·1 citations·filing 2014–2022
81Inventor score
Top patents by PatentIndex Score
14 records- 0176US12448413B2HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cellNEC CORP·Filed 2022·Granted Oct 21, 2025·0 cites·6 claims
- 0275US11304997B2HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cellCYTLIMIC INC·Filed 2019·Granted Apr 19, 2022·0 cites·5 claims
- 0371US10450601B2Buffer composition for hybridization use, and hybridization methodTOYO KOHAN CO LTD·Filed 2014·Granted Oct 22, 2019·1 cites·5 claims
- 0468US10875900B2Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cellsCYTLIMIC INC·Filed 2020·Granted Dec 29, 2020·0 cites·8 claims
- 0567US10590179B2Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cellsCYTLIMIC INC·Filed 2018·Granted Mar 17, 2020·0 cites·2 claims
- 0664US11618770B2MUC1-derived peptide, and pharmaceutical composition for treatment or prevention of cancer, immunity-inducing agent and method for manufacturing antigen presenting cell using sameNEC CORP·Filed 2020·Granted Apr 4, 2023·0 cites·4 claims
- 0759US10526388B2Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using the same, immunity inducer, and method for producing antigen-presenting cellsCYTLIMIC INC·Filed 2016·Granted Jan 7, 2020·0 cites·9 claims
- 0858US11692216B2Method for assisting prediction of risk of occurrence of side effect of irinotecanUNIV YAMAGUCHI·Filed 2020·Granted Jul 4, 2023·0 cites·8 claims
- 0953US11384385B2Method for predicting therapeutic effects of irinotecan, and kit for sameUNIV YAMAGUCHI·Filed 2018·Granted Jul 12, 2022·0 cites·2 claims
- 1053US10537626B2HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cellCYTLIMIC INC·Filed 2015·Granted Jan 21, 2020·0 cites·2 claims
- 1152US2018057531A1Muc1-derived peptide, and pharmaceutical composition for treatment or prevention of cancer, immunity-inducing agent and method for manufacturing antigen presenting cell using sameNEC CORP·Filed 2016·Application pending·0 cites
- 1251US2022401540A1Pharmaceutical compositionCYTLIMIC INC·Filed 2020·Application pending·0 cites
- 1350US2018237833A1Method for assisting prediction of risk of occurrence of side effect of irinotecanUNIV YAMAGUCHI·Filed 2016·Application pending·0 cites
- 1441US11111526B2Buffer composition for hybridization and hybridization methodTOYO KOHAN CO LTD·Filed 2017·Granted Sep 7, 2021·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Shoichi Hazama files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →